Retina Long term safety of ranibizumab in neovascular age-related macular degeneration: SECURE Study by NeLM - Ophthalmology • 2012/10/19 • 0 Comments Source: Ophthalmology Area: News The long-term safety of intravitreal ranibizumab 0.5-mg injections in neovascular age-related macular degeneration has been assessed in a 24 month open-label, multicentre, phase IV extension study (SECURE). Full Story →